This company has been marked as potentially delisted and may not be actively trading.

OvaScience (OVAS) Competitors

OVAS vs. WHWK, CNTN, MENS, ANTX, and TTRX

Should you be buying OvaScience stock or one of its competitors? The main competitors of OvaScience include Whitehawk Therapeutics (WHWK), Hillstream Biopharma (CNTN), Jyong Biotech (MENS), Anthem (ANTX), and Turn Therapeutics (TTRX).

How does OvaScience compare to Whitehawk Therapeutics?

OvaScience (NASDAQ:OVAS) and Whitehawk Therapeutics (NASDAQ:WHWK) are both small-cap pharmaceutical preparations industry companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

: Whitehawk Therapeutics has a net margin of 0.00% compared to OvaScience's net margin of -10,128.37%. OvaScience's return on equity of -47.06% beat Whitehawk Therapeutics' return on equity.
Company Net Margins Return on Equity Return on Assets
OvaScience -10,128.37% -47.06% -42.39%
Whitehawk Therapeutics N/A -62.88% -58.98%
: OvaScience has a beta of 3.11, suggesting that its stock price is 211% more volatile than the S&P 500. Comparatively, Whitehawk Therapeutics has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500.
: 22.5% of OvaScience shares are owned by institutional investors. Comparatively, 52.1% of Whitehawk Therapeutics shares are owned by institutional investors. 7.4% of OvaScience shares are owned by company insiders. Comparatively, 49.9% of Whitehawk Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
: Whitehawk Therapeutics has higher revenue and earnings than OvaScience.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OvaScience $290K 192.74 -$50.97M N/A N/A
Whitehawk Therapeutics $7.14M 29.15 -$20.60M $0.47 8.96
: In the previous week, Whitehawk Therapeutics had 2 more articles in the media than OvaScience. MarketBeat recorded 2 mentions for Whitehawk Therapeutics and 0 mentions for OvaScience. Whitehawk Therapeutics' average media sentiment score of 1.16 beat OvaScience's score of 0.00 indicating that Whitehawk Therapeutics is being referred to more favorably in the news media.
Company Overall Sentiment
OvaScience Neutral
Whitehawk Therapeutics Positive
: Whitehawk Therapeutics has a consensus price target of $7.00, suggesting a potential upside of 66.27%. Given Whitehawk Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Whitehawk Therapeutics is more favorable than OvaScience.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OvaScience
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Whitehawk Therapeutics
1 Sell rating(s)

1 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.50

Company	Net Margins	Return on Equity	Return on Assets
OvaScience	-10,128.37%	-47.06%	-42.39%
Whitehawk Therapeutics	N/A	-62.88%	-58.98%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OvaScience	$290K	192.74	-$50.97M	N/A	N/A
Whitehawk Therapeutics	$7.14M	29.15	-$20.60M	$0.47	8.96

Company	Overall Sentiment
OvaScience	Neutral
Whitehawk Therapeutics	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OvaScience	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Whitehawk Therapeutics	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Whitehawk Therapeutics beats OvaScience on 10 of the 14 factors compared between the two stocks.

How does OvaScience compare to Hillstream Biopharma?

OvaScience (NASDAQ:OVAS) and Hillstream Biopharma (NASDAQ:CNTN) are both small-cap pharmaceutical preparations industry companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

: Hillstream Biopharma has a net margin of 0.00% compared to OvaScience's net margin of -10,128.37%. Hillstream Biopharma's return on equity of -35.59% beat OvaScience's return on equity.
Company Net Margins Return on Equity Return on Assets
OvaScience -10,128.37% -47.06% -42.39%
Hillstream Biopharma N/A -35.59% -27.05%
: OvaScience has a beta of 3.11, meaning that its share price is 211% more volatile than the S&P 500. Comparatively, Hillstream Biopharma has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500.
: 22.5% of OvaScience shares are owned by institutional investors. Comparatively, 1.2% of Hillstream Biopharma shares are owned by institutional investors. 7.4% of OvaScience shares are owned by insiders. Comparatively, 6.7% of Hillstream Biopharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
: Hillstream Biopharma has lower revenue, but higher earnings than OvaScience.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OvaScience $290K 192.74 -$50.97M N/A N/A
Hillstream Biopharma N/A N/A -$35.92M -$3.99 N/A
: In the previous week, OvaScience's average media sentiment score of 0.00 equaled Hillstream Biopharma'saverage media sentiment score.
Company Overall Sentiment
OvaScience Neutral
Hillstream Biopharma Neutral
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OvaScience
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Hillstream Biopharma
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00

Company	Net Margins	Return on Equity	Return on Assets
OvaScience	-10,128.37%	-47.06%	-42.39%
Hillstream Biopharma	N/A	-35.59%	-27.05%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OvaScience	$290K	192.74	-$50.97M	N/A	N/A
Hillstream Biopharma	N/A	N/A	-$35.92M	-$3.99	N/A

Company	Overall Sentiment
OvaScience	Neutral
Hillstream Biopharma	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OvaScience	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Hillstream Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Hillstream Biopharma beats OvaScience on 5 of the 9 factors compared between the two stocks.

How does OvaScience compare to Jyong Biotech?

OvaScience (NASDAQ:OVAS) and Jyong Biotech (NASDAQ:MENS) are both small-cap pharmaceutical preparations industry companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

: Jyong Biotech has a net margin of 0.00% compared to OvaScience's net margin of -10,128.37%. Jyong Biotech's return on equity of 0.00% beat OvaScience's return on equity.
Company Net Margins Return on Equity Return on Assets
OvaScience -10,128.37% -47.06% -42.39%
Jyong Biotech N/A N/A N/A
: 22.5% of OvaScience shares are owned by institutional investors. 7.4% of OvaScience shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
: Jyong Biotech has lower revenue, but higher earnings than OvaScience.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OvaScience $290K 192.74 -$50.97M N/A N/A
Jyong Biotech N/A N/A N/A N/A N/A
: In the previous week, Jyong Biotech had 2 more articles in the media than OvaScience. MarketBeat recorded 2 mentions for Jyong Biotech and 0 mentions for OvaScience. OvaScience's average media sentiment score of 0.00 equaled Jyong Biotech'saverage media sentiment score.
Company Overall Sentiment
OvaScience Neutral
Jyong Biotech Neutral
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OvaScience
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Jyong Biotech
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00

Company	Net Margins	Return on Equity	Return on Assets
OvaScience	-10,128.37%	-47.06%	-42.39%
Jyong Biotech	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OvaScience	$290K	192.74	-$50.97M	N/A	N/A
Jyong Biotech	N/A	N/A	N/A	N/A	N/A

Company	Overall Sentiment
OvaScience	Neutral
Jyong Biotech	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OvaScience	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Jyong Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Jyong Biotech beats OvaScience on 5 of the 8 factors compared between the two stocks.

How does OvaScience compare to Anthem?

Anthem (NASDAQ:ANTX) and OvaScience (NASDAQ:OVAS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anthem
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
OvaScience
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: Anthem has a beta of -0.95, meaning that its stock price is 195% less volatile than the S&P 500. Comparatively, OvaScience has a beta of 3.11, meaning that its stock price is 211% more volatile than the S&P 500.
: Anthem has a net margin of 0.00% compared to OvaScience's net margin of -10,128.37%. OvaScience's return on equity of -47.06% beat Anthem's return on equity.
Company Net Margins Return on Equity Return on Assets
Anthem N/A -55.04% -49.13%
OvaScience -10,128.37% -47.06% -42.39%
: Anthem has higher earnings, but lower revenue than OvaScience.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Anthem N/A N/A -$35.17M -$1.16 N/A
OvaScience $290K 192.74 -$50.97M N/A N/A
: 90.5% of Anthem shares are owned by institutional investors. Comparatively, 22.5% of OvaScience shares are owned by institutional investors. 20.8% of Anthem shares are owned by insiders. Comparatively, 7.4% of OvaScience shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: In the previous week, Anthem had 6 more articles in the media than OvaScience. MarketBeat recorded 6 mentions for Anthem and 0 mentions for OvaScience. Anthem's average media sentiment score of 0.00 equaled OvaScience'saverage media sentiment score.
Company Overall Sentiment
Anthem Neutral
OvaScience Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anthem	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
OvaScience	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
Anthem	N/A	-55.04%	-49.13%
OvaScience	-10,128.37%	-47.06%	-42.39%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anthem	N/A	N/A	-$35.17M	-$1.16	N/A
OvaScience	$290K	192.74	-$50.97M	N/A	N/A

Company	Overall Sentiment
Anthem	Neutral
OvaScience	Neutral

Summary

Anthem beats OvaScience on 6 of the 10 factors compared between the two stocks.

How does OvaScience compare to Turn Therapeutics?

Turn Therapeutics (NASDAQ:TTRX) and OvaScience (NASDAQ:OVAS) are both small-cap pharmaceutical preparations industry companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

: Turn Therapeutics currently has a consensus price target of $8.00, suggesting a potential upside of 116.22%. Given Turn Therapeutics' stronger consensus rating and higher probable upside, equities research analysts clearly believe Turn Therapeutics is more favorable than OvaScience.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Turn Therapeutics
1 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
OvaScience
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: Turn Therapeutics has a net margin of 0.00% compared to OvaScience's net margin of -10,128.37%. Turn Therapeutics' return on equity of 0.00% beat OvaScience's return on equity.
Company Net Margins Return on Equity Return on Assets
Turn Therapeutics N/A N/A N/A
OvaScience -10,128.37% -47.06% -42.39%
: Turn Therapeutics has higher earnings, but lower revenue than OvaScience.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Turn Therapeutics N/A N/A -$3.19M -$0.16 N/A
OvaScience $290K 192.74 -$50.97M N/A N/A
: 22.5% of OvaScience shares are owned by institutional investors. 7.4% of OvaScience shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: In the previous week, Turn Therapeutics' average media sentiment score of 0.00 equaled OvaScience'saverage media sentiment score.
Company Overall Sentiment
Turn Therapeutics Neutral
OvaScience Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Turn Therapeutics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
OvaScience	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
Turn Therapeutics	N/A	N/A	N/A
OvaScience	-10,128.37%	-47.06%	-42.39%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Turn Therapeutics	N/A	N/A	-$3.19M	-$0.16	N/A
OvaScience	$290K	192.74	-$50.97M	N/A	N/A

Company	Overall Sentiment
Turn Therapeutics	Neutral
OvaScience	Neutral

Summary

Turn Therapeutics beats OvaScience on 7 of the 10 factors compared between the two stocks.

Get OvaScience News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OVAS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OVAS vs. The Competition

Export

Metric	OvaScience	Pharmaceutical Preparations Industry	Medical Sector	NASDAQ Exchange
Market Cap	$55.90M	$883.41M	$6.25B	$11.76B
Dividend Yield	N/A	4.84%	2.74%	5.26%
P/E Ratio	N/A	1.71	29.24	27.07
Price / Sales	192.74	119.23	504.68	73.40
Price / Cash	N/A	20.07	43.30	53.90
Price / Book	0.87	7.60	9.67	6.69
Net Income	-$50.97M	-$4.80M	$3.55B	$332.64M

OvaScience Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OVAS OvaScience	N/A	$1.56 flat	N/A	-77.7%	$55.90M	$290K	N/A	N/A	Gap Up
WHWK Whitehawk Therapeutics	4.0577 of 5 stars	$4.03 -3.4%	$7.00 +73.7%	N/A	$196.81M	$7.15M	8.57	21
CNTN Hillstream Biopharma	0.0782 of 5 stars	$3.41 +1.2%	N/A	N/A	$190.93M	N/A	N/A	2	Positive News
MENS Jyong Biotech	N/A	$2.19 -3.5%	N/A	N/A	$166.50M	N/A	N/A	31
ANTX Anthem	0.1857 of 5 stars	$4.34 +1.4%	$2.00 -53.9%	+294.1%	$154.06M	N/A	N/A	N/A	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OVAS) was last updated on 5/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OvaScience (OVAS) Competitors

OVAS vs. WHWK, CNTN, MENS, ANTX, and TTRX

How does OvaScience compare to Whitehawk Therapeutics?

Summary

How does OvaScience compare to Hillstream Biopharma?

Summary

How does OvaScience compare to Jyong Biotech?

Summary

How does OvaScience compare to Anthem?

Summary

How does OvaScience compare to Turn Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OVAS vs. The Competition

OvaScience Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OvaScience (OVAS) Competitors

OVAS vs. WHWK, CNTN, MENS, ANTX, and TTRX

How does OvaScience compare to Whitehawk Therapeutics?

Summary

How does OvaScience compare to Hillstream Biopharma?

Summary

How does OvaScience compare to Jyong Biotech?

Summary

How does OvaScience compare to Anthem?

Summary

How does OvaScience compare to Turn Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OVAS vs. The Competition

OvaScience Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools